Summary
Joey Azofeifa is a computational biologist and entrepreneurial leader with 12 years of experience at the intersection of statistics, genomics, and machine learning. As CEO and co-founder of Arpeggio Bio, he leads an AI- and robotics-driven startup focused on combating cancer drug resistance, backed by Y Combinator and over $20M in venture funding. His prior roles at Merck and Forma Therapeutics combined novel unsupervised and probabilistic modeling with hands-on sequencing and multi-omics pipeline development, translating complex experimental data into actionable biological insight. He holds a PhD in Computer Science from the University of Colorado Boulder and a background in biochemistry from Vassar, enabling him to bridge wet-lab intuition with rigorous computational methods. Colleagues describe him as someone who builds cross-disciplinary teams that blend biology, chemistry, and data science—a maker who writes the models and also scales them to automated lab workflows.
11 years of coding experience
2 years of employment as a software developer
S19 batch, S19 batch at Y Combinator
Biochemistry and Molecular Biology, Biochemistry and Molecular Biology at Vassar College
Doctor of Philosophy (Ph.D.) Computer Science, Doctor of Philosophy (Ph.D.) Computer Science at University of Colorado Boulder
English